Trials / Not Yet Recruiting
Not Yet RecruitingNCT06760650
Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease
Fluorescein-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Saint-Joseph University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Our study hypothesizes that fluorescein exposure in diabetic patients with advanced chronic kidney disease results in deterioration of kidney function. It will therefore aim to evaluate the incidence of acute kidney injury induced by fluorescein in diabetic patients with CKD. The objective is to determine the incidence, severity and risk factors associated with this deterioration to improve the care of this specific population.
Detailed description
This study will assess the change in serum creatinine in patients with diabetes and advanced chronic kidney disease, after a fluorescein angiography. This is a before and after study that will include 35 patients from the department of ophtalmology over 6 months with a total follow-up for 3 months.
Conditions
- Chronic Kidney Disease Stage 4
- Chronic Kidney Disease Stage 3B
- Chronic Kidney Disease Stage 5
- Diabetes Mellitus
- Fluorescein Angiography
- Acute Kidney Injury
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Fluorescein angiography | Fluorescein angiography |
Timeline
- Start date
- 2025-01-07
- Primary completion
- 2025-10-10
- Completion
- 2025-10-10
- First posted
- 2025-01-07
- Last updated
- 2025-01-07
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT06760650. Inclusion in this directory is not an endorsement.